- Home
- ARGX vs BKR Comparison
ARGX vs BKR Comparison
Compare ARGX & BKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- BKR
- Stock Information
- Founded
- ARGX 2008
- BKR 2016
- Country
- ARGX Netherlands
- BKR United States
- Employees
- ARGX N/A
- BKR N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- BKR Metal Fabrications
- Sector
- ARGX Health Care
- BKR Industrials
- Exchange
- ARGX Nasdaq
- BKR Nasdaq
- Market Cap
- ARGX 40.4B
- BKR 40.5B
- IPO Year
- ARGX 2017
- BKR N/A
- Fundamental
- Price
- ARGX $596.20
- BKR $38.91
- Analyst Decision
- ARGX Strong Buy
- BKR Strong Buy
- Analyst Count
- ARGX 20
- BKR 20
- Target Price
- ARGX $699.56
- BKR $49.89
- AVG Volume (30 Days)
- ARGX 465.0K
- BKR 10.0M
- Earning Date
- ARGX 05-08-2025
- BKR 04-22-2025
- Dividend Yield
- ARGX N/A
- BKR 2.41%
- EPS Growth
- ARGX N/A
- BKR 56.02
- EPS
- ARGX 12.78
- BKR 2.98
- Revenue
- ARGX $2,248,205,000.00
- BKR $27,829,000,000.00
- Revenue This Year
- ARGX $57.86
- BKR $0.68
- Revenue Next Year
- ARGX $31.90
- BKR $3.77
- P/E Ratio
- ARGX $43.64
- BKR $13.06
- Revenue Growth
- ARGX 77.22
- BKR 9.11
- 52 Week Low
- ARGX $352.77
- BKR $30.93
- 52 Week High
- ARGX $678.21
- BKR $49.40
- Technical
- Relative Strength Index (RSI)
- ARGX 51.80
- BKR 44.44
- Support Level
- ARGX $583.00
- BKR $34.07
- Resistance Level
- ARGX $610.06
- BKR $38.55
- Average True Range (ATR)
- ARGX 24.42
- BKR 2.13
- MACD
- ARGX 4.74
- BKR -0.06
- Stochastic Oscillator
- ARGX 84.66
- BKR 46.58
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About BKR Baker Hughes Company
Following a 2022 reorganization, Baker Hughes operates across two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment, or OFSE, is one of the Big Three oilfield service players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three quarters of the firm's OFSE. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services across various energy and industrial applications.